Biomark Diagnostics Inc.

OTCPK:BMKD.F Stock Report

Market Cap: US$42.1m

Biomark Diagnostics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BMKD.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Apr 26BuyUS$1,046Rashid Ahmed BuxIndividual2,500US$0.42
02 Apr 26BuyUS$431Guoyu HuangIndividual1,000US$0.43
25 Mar 26BuyUS$863Rashid Ahmed BuxIndividual2,000US$0.44
17 Mar 26BuyUS$452Rashid Ahmed BuxIndividual1,000US$0.45
16 Mar 26BuyUS$438Guoyu HuangIndividual1,000US$0.44
13 Mar 26BuyUS$451Rashid Ahmed BuxIndividual1,000US$0.45
12 Mar 26BuyUS$231Guoyu HuangIndividual500US$0.46
06 Mar 26BuyUS$220Rashid Ahmed BuxIndividual500US$0.44
06 Mar 26BuyUS$224Guoyu HuangIndividual500US$0.45
27 Feb 26BuyUS$1,121Rashid Ahmed BuxIndividual2,750US$0.42
26 Feb 26BuyUS$804Guoyu HuangIndividual2,000US$0.40
19 Feb 26BuyUS$603Rashid Ahmed BuxIndividual1,500US$0.42
10 Feb 26BuyUS$366Rashid Ahmed BuxIndividual1,000US$0.37
06 Feb 26BuyUS$183Rashid Ahmed BuxIndividual500US$0.37
03 Feb 26BuyUS$707Rashid Ahmed BuxIndividual2,000US$0.35
30 Jan 26BuyUS$184Rashid Ahmed BuxIndividual500US$0.37
23 Jan 26BuyUS$371Rashid Ahmed BuxIndividual1,000US$0.37
15 Jan 26BuyUS$684Rashid Ahmed BuxIndividual2,000US$0.35
12 Jan 26BuyUS$2,011Rashid Ahmed BuxIndividual6,000US$0.35
12 Jan 26BuyUS$1,298Guoyu HuangIndividual4,000US$0.32
31 Dec 25BuyUS$1,056Rashid Ahmed BuxIndividual3,000US$0.35
23 Dec 25BuyUS$1,340Rashid Ahmed BuxIndividual4,000US$0.34
23 Dec 25BuyUS$700Guoyu HuangIndividual2,000US$0.35
19 Dec 25BuyUS$1,627Rashid Ahmed BuxIndividual5,000US$0.33
19 Dec 25BuyUS$654Guoyu HuangIndividual2,000US$0.33
05 Dec 25BuyUS$343Guoyu HuangIndividual1,000US$0.34
05 Dec 25BuyUS$34,264Guoyu HuangIndividual100,000US$0.34
05 Dec 25SellUS$34,264Bux Investments Ltd.Company100,000US$0.34
03 Dec 25BuyUS$344Rashid Ahmed BuxIndividual1,000US$0.34
01 Dec 25BuyUS$2,079Rashid Ahmed BuxIndividual7,500US$0.35
28 Nov 25BuyUS$1,088Guoyu HuangIndividual4,000US$0.27
16 Oct 25BuyUS$1,253Rashid Ahmed BuxIndividual5,500US$0.23
16 Oct 25BuyUS$1,816Guoyu HuangIndividual8,000US$0.24
09 Oct 25BuyUS$1,002Guoyu HuangIndividual4,000US$0.26
07 Oct 25BuyUS$377Rashid Ahmed BuxIndividual1,500US$0.25
03 Oct 25BuyUS$4,329Rashid Ahmed BuxIndividual19,500US$0.22
03 Oct 25BuyUS$2,029Guoyu HuangIndividual9,000US$0.23
24 Sep 25BuyUS$468Rashid Ahmed BuxIndividual2,000US$0.23
24 Sep 25BuyUS$1,022Guoyu HuangIndividual4,500US$0.24
15 Sep 25BuyUS$525Guoyu HuangIndividual2,000US$0.26
29 Aug 25BuyUS$1,701Rashid Ahmed BuxIndividual7,000US$0.27
29 Aug 25BuyUS$247Guoyu HuangIndividual1,000US$0.25
21 Aug 25BuyUS$819Guoyu HuangIndividual3,200US$0.26
20 Aug 25BuyUS$768Rashid Ahmed BuxIndividual3,000US$0.26
24 Jul 25BuyUS$741Guoyu HuangIndividual3,000US$0.25
21 Jul 25BuyUS$490Rashid Ahmed BuxIndividual2,000US$0.24
15 Jul 25BuyUS$496Rashid Ahmed BuxIndividual2,000US$0.25
09 Jul 25BuyUS$378Rashid Ahmed BuxIndividual1,500US$0.25
04 Jul 25BuyUS$910Rashid Ahmed BuxIndividual3,600US$0.26
02 Jul 25BuyUS$704Rashid Ahmed BuxIndividual3,000US$0.23
18 Jun 25BuyUS$708Rashid Ahmed BuxIndividual3,000US$0.24
11 Jun 25BuyUS$258Rashid Ahmed BuxIndividual1,100US$0.23
02 Jun 25BuyUS$891Rashid Ahmed BuxIndividual4,000US$0.22
30 May 25BuyUS$236Rashid Ahmed BuxIndividual1,000US$0.24
29 May 25BuyUS$2,086Rashid Ahmed BuxIndividual9,600US$0.22
16 May 25BuyUS$5,650Rashid Ahmed BuxIndividual30,400US$0.19
14 Apr 25BuyUS$180Rashid Ahmed BuxIndividual1,000US$0.18

Insider Trading Volume

Insider Buying: BMKD.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BMKD.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders13,127,12612.5%
Private Companies43,691,40541.6%
General Public48,271,68245.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 6 shareholders own 54.07% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
39%
Biomark Technologies Inc
41,004,167US$16.4m0%no data
4.99%
James Lavender
5,239,783US$2.1m0%no data
4.75%
Guoyu Huang
4,989,112US$2.0m0.18%no data
2.76%
Rashid Ahmed Bux
2,898,231US$1.2m0.84%no data
2.16%
Bux Investments Ltd.
2,275,150US$910.7k-28.4%no data
0.39%
Grg Consulting Ltd.
412,088US$165.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/10 01:28
End of Day Share Price 2026/04/06 00:00
Earnings2025/12/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biomark Diagnostics Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.